Holger Wesche

Dr. Wesche joined Harpoon Therapeutics with 20 years of biotech experience focused on target validation, drug discovery and drug development as well as multi-site project management in the fields of oncology and inflammation. His previous role was as scientific director at Amgen where he was responsible for cross-functional organization and coordination of the next generation BiTE platform, the industry’s leading T-cell engaging antibody platform. He also led several drug discovery projects through pre-clinical development. Dr. Wesche is co-author of numerous publications and several US patents. Dr. Wesche received his PhD, summa cum laude, in biochemistry and Immunology from the University of Hannover, Germany.

Holger Wesche is the SENIOR VICE PRESIDENT at Harpoon Therapeutics. With a background in Biotechnology, Holger Wesche has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.